CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SNYNF

Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine (MenACYW Conjugate Vaccine)

Phase 3
Sanofi (SNYNF)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Meningococcal Immunisation (Healthy Volunteers)

SNYMeningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid Conjugate vaccine MenACYW Conjugate vaccine
Phase 3
View Full Landscape
Drug Information

Target Indication

Meningococcal Immunisation (Healthy Volunteers)

Clinical Trial

NCT04368429

Last updated: 2/19/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Source: FDA Orange Book
Drug Science
Mechanism of action & safety profile
Developer

SNYNF

Sanofi

Biotechnology•North America•NASDAQ
Related Pipeline
IrbesartanPhase 3

Atrial Fibrillation

Teriflunomide (HMR1726)Phase 3

Multiple Sclerosis

DTaP-IPV-HB-PRP~T vaccinePhase 3

Diphtheria

Insulin glargine/lixisenatide Fixed Ratio CombinationPhase 3

Type 2 Diabetes

teriflunomide HMR1726Phase 3

Multiple Sclerosis

View full pipeline
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.